Cargando…
Slow, but complete, resolution of mitomycin-induced refractory thrombotic thrombocytopenic purpura after rituximab treatment
Thrombotic thrombocytopenic purpura (TTP) is a critical complication of treatment with mitomycin C. We retrospectively describe the case of a patient with progressive renal cell carcinoma and mitomycin-induced TTP refractory to plasma exchange and glucocorticoids; we describe the clinical course, su...
Autores principales: | Hong, Mi Jin, Lee, Hong Ghi, Hur, Mina, Kim, Sung Yong, Cho, Yo Han, Yoon, So Young |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065627/ https://www.ncbi.nlm.nih.gov/pubmed/21461304 http://dx.doi.org/10.5045/kjh.2011.46.1.45 |
Ejemplares similares
-
Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
por: Chaurasiya, Prem Shankar, et al.
Publicado: (2022) -
Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012) -
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017) -
Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases
por: Omri, Halima El, et al.
Publicado: (2015) -
Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report
por: Chen, Jian, et al.
Publicado: (2020)